Answers are grounded in this paper and cite their sources.
We describe the design and synthesis of α‐azido‐4‐thioribose and α‐epoxycarbaribose‐based adenosine diphosphate ribose (ADP‐ribose) analogs as potent inhibitors of the SARS‐CoV‐2 macrodomain Mac1. The α‐epoxycarbaribose was designed to emulate the structure of the distal ribose of ADPr, which adopts an E 3 conformation during hydrolysis and release from the target protein. In addition, a sulfonyl carbamate linker and the remdesivir‐inspired nucleobase GS‐441524 were incorporated into our designs to increase inhibitor lipophilicity and potency, respectively. The α‐epoxycarbaribose GS‐441524 pyrophosphate was identified as the most potent Mac1 inhibitor to date, exhibiting low‐nanomolar affinity. Replacing pyrophosphate with the less polar sulfonyl carbamate linker yielded an inhibitor with an IC50 of 19 nM. Analysis of co‐crystal structures of Mac1 and its inhibitors showed that the epoxide is intact and revealed that the sulfonyl carbamate linker positions itself to mimic pyrophosphate binding.
No takes yet. Share an insight, caveat, or question.
Rijpkema et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: